MSAB
MSAB is a selective inhibitor of Wnt/β-catenin signaling. MSAB binds to β-catenin, promoting its degradation, and specifically downregulates Wnt/β-catenin target genes.MSAB act against Wnt/β-catenin signaling and identified as a selective inhibitor of Wnt/β-catenin signaling. MSAB shows potent anti-tumor effects selectively on Wnt-dependent cancer cells in vitro and in mouse cancer models. MSAB binds to β-catenin, promoting its degradation, and specifically downregulates Wnt/β-catenin target genes. might represent an effective therapeutic strategy for cancers addicted to the Wnt/β-catenin signaling pathway.
Product Specifications
CAS Number
173436-66-3
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 250 mg/mL (818.73 mM)
Smiles
COC (=O) c1cccc (NS (=O) (=O) c2ccc (C) cc2) c1
Molecular Formula
C15H15NO4S
Molecular Weight
305.35
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
FOXP2, CT (Forkhead Box P2, Forkhead Box Protein P2, CAG Repeat Protein 44, CAGH44, SPCH1, Trinucleotide Repeat-containing Gene 10 Protein, TNRC10) (MaxLight 550) discontinued
1- (1H-1,2,3,4-Tetrazol-1-yl) cyclopropane-1-carboxylic acid
1- (1H-1,2,3,4-Tetrazol-1-yl) cyclopropane-1-carboxylic acid
7β,15α-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8,20-dien-24-oic acid
7β,15α-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8,20-dien-24-oic acid